← Leaderboards
Alison Donnelly Axtman
Emory University
$1,629,616
Attributed
$1,629,616
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.2M · FY2022–25$10M$7.5M$5M$2.5M$0
'22
'23
'24
'25
Funding mix
By agency
NIH$15,979,723 · 2
By mechanism
U54$14,350,107 · 1
R56$1,629,616 · 1
Top collaborators
- Gregory W Carter2 shared
- Aled M Edwards2 shared
- Haian Fu2 shared
- Anna K Greenwood2 shared
- Allan I Levey2 shared
- Frank M Longo2 shared
- Paul Brennan1 shared
- Emma Mead1 shared
Most similar at Emory University
Same institution · by research overlap
- Allan I Levey$89,469,218
- Haian Fu$16,783,892
- Yong Wan$11,312,987
- M Elizabeth Halloran$14,984,665
- Peng Jin$28,132,987
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposValidationAnimal ModelNeurodegenerative DisordersS Disease ModelS DiseaseCommunitiesDrug TargetingInterestIn VivoPharmaceutical PreparationsProgramsResearch PersonnelScreeningEffective TherapyBiologyDesignDisease ProgressionPathway InteractionsEvaluationInvestigationIn VitroAmyloidProteins
Grant awards (4)
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy$796,443
R56 · FY2025 · AG · contact PI
Optimization of a potent and cell active CK2 chemical probe for Alzheimer's disease therapy$833,173
R56 · FY2024 · AG · contact PI
Open Drug Discovery Center for Alzheimer's Disease$7,132,571
U54 · FY2023 · AG
Open Drug Discovery Center for Alzheimer's Disease$7,217,536
U54 · FY2022 · AG